Marigold Corporation made the following purchases of investments during 2023, the first year in which Marigold invested in equity securities: 1. On Jarnuary 15, it purchased 8,190 shares of Nirmala Corp's common shares at $3050 per share plus commission of $1.803 2. On April 1, it purchased 4,550 shares of Oxana Corp's common shares at $47 per share plus commisaion of 53,067 . 3. On September 10, it purchased 6,370 shares of WTA Corp's preferred shares at $24,10 per share plus commission of $2,648. On May 20, 2023. Marigold sold 2.730 of the Nirmala common shares at a market price of 532 per share less brokerage commissions of $2.594. The year-end fair values per share were as follows Nirmala $27, Oxana \$ 50 . and WTA $25. The chief accountant of Marigold tells yod that Marigold holds these investments with the intention of selling them to earn short-term profits from appreciation in their prices and accounts for them using the FV-NI model. Marigold follows iFRS: (a) Prepare the journal entries to record the thrce investments. (Credit occount titles ore outomatically indented when the omount is entered. Do not indent monually. If no entry is required, select "No Entry" for the occount titles and enter 0 for the amounts. Record entries in the order disployed in the problem statement. List oll debit entries before credit entries)